Certolizumab pegol attenuates the proinflammatory state in endothelial cells in a manner that is atheroprotective.

SK Heathfield, B Parker, [Unknown] Zeef, Bruce IN. LAH., MY Alexander

Research output: Contribution to journal › Article › peer-review

Cite this

@article{20180bf72b2e4a10a99f0ac495642175,

title = "Certolizumab pegol attenuates the proinflammatory state in endothelial cells in a manner that is atheroprotective.",

author = "SK Heathfield and B Parker and [Unknown] Zeef and LAH., {Bruce IN.} and MY Alexander",

year = "2012",

language = "English",

journal = "Clinical & Exp Rheumatology",

issn = "1593-098X",

publisher = "Pacini Editore s.r.l.",

}